An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan by Chang, Hsien-Yen & Weiner, Jonathan P
RESEARCH ARTICLE Open Access
An in-depth assessment of a diagnosis-based risk
adjustment model based on national health
insurance claims: the application of the Johns
Hopkins Adjusted Clinical Group case-mix system
in Taiwan
Hsien-Yen Chang
*, Jonathan P Weiner
Abstract
Background: Diagnosis-based risk adjustment is becoming an important issue globally as a result of its
implications for payment, high-risk predictive modelling and provider performance assessment. The Taiwanese
National Health Insurance (NHI) programme provides universal coverage and maintains a single national
computerized claims database, which enables the application of diagnosis-based risk adjustment. However,
research regarding risk adjustment is limited. This study aims to examine the performance of the Adjusted Clinical
Group (ACG) case-mix system using claims-based diagnosis information from the Taiwanese NHI programme.
Methods: A random sample of NHI enrollees was selected. Those continuously enrolled in 2002 were included for
concurrent analyses (n = 173,234), while those in both 2002 and 2003 were included for prospective analyses (n =
164,562). Health status measures derived from 2002 diagnoses were used to explain the 2002 and 2003 health
expenditure. A multivariate linear regression model was adopted after comparing the performance of seven
different statistical models. Split-validation was performed in order to avoid overfitting. The performance measures
were adjusted R
2 and mean absolute prediction error of five types of expenditure at individual level, and predictive
ratio of total expenditure at group level.
Results: The more comprehensive models performed better when used for explaining resource utilization.
Adjusted R
2 of total expenditure in concurrent/prospective analyses were 4.2%/4.4% in the demographic model,
15%/10% in the ACGs or ADGs (Aggregated Diagnosis Group) model, and 40%/22% in the models containing EDCs
(Expanded Diagnosis Cluster). When predicting expenditure for groups based on expenditure quintiles, all models
underpredicted the highest expenditure group and overpredicted the four other groups. For groups based on
morbidity burden, the ACGs model had the best performance overall.
Conclusions: Given the widespread availability of claims data and the superior explanatory power of claims-based
risk adjustment models over demographics-only models, Taiwan’s government should consider using claims-based
models for policy-relevant applications. The performance of the ACG case-mix system in Taiwan was comparable to
that found in other countries. This suggested that the ACG system could be applied to Taiwan’s NHI even though
it was originally developed in the USA. Many of the findings in this paper are likely to be relevant to other
diagnosis-based risk adjustment methodologies.
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Risk adjustment has become an increasingly important
tool in healthcare around the globe. It is being extensively
applied to provider performance assessment [1-3], high
risk predictive modelling for disease management [4-6]
and payment adjustment [7-10]. Through these applica-
tions the broader goals of equity, efficiency and improved
outcomes may be achieved in a healthcare system. Health
indicators that are often used for risk adjustment include
demographic factors, subjective/self-reported health status
[11,12], biomedical clinical indicators [13,14], prior expen-
diture [15,16] and claims-based morbidity burden indica-
tors (using diagnostic codes [17,18] or medication codes
[9,19-21]). Even though demographic factors are most
often used given the availability of the data, both prior-
expenditure and claims-based health indicators perform
much better than demographic factors [8,9,13,14,16,19,22].
However, since risk adjustment models are usually
adopted for payment adjustment, models using diagnosis
and/or pharmacy data are preferred as prior use models
could offer inappropriate incentives to increase services in
order to receive higher payments. Diagnosis and/or phar-
macy-based risk adjustment models have been developed
and gradually adopted in Canada, the USA and Europe
[9,23-29].
The Johns Hopkins Adjusted Clinical Group (ACG)
system is a comprehensive risk adjustment software that
incorporates diagnosis information, pharmacy informa-
tion, or both, to capture an individual’s morbidity bur-
den [23,24,30]; ACG actuarial cells and Aggregated
Diagnosis Group (ADG) binary morbidity markers have
been extensively examined in the USA [8,16], Canada
[31] and other European countries [32]. However,
Expanded Diagnosis Clusters (EDCs), another output of
the ACG system, have not been assessed carefully in
terms of performance on risk adjustment. EDCs are bin-
ary indicators which show whether or not an individual
has specific diseases/symptoms. It has been shown that
a substantial fraction of health costs resulted from the
treatment of a relatively small number of common, but
expensive, chronic diseases [15]. Therefore, our supposi-
tion is that the basic ACG models can be improved
upon by the inclusion of selected disease conditions
(represented by EDCs) [17].
Taiwan launched a government-run, single-payer
National Health Insurance (NHI) programme in May
1995. All Taiwanese nationals are obligated by law to
join this programme to ensure adequate risk pooling.
Under the jurisdiction of the national government’s
Department of Health, the NHI is administered by the
Bureau of National Health Insurance (BNHI) and six
regional branches are in charge of administrating the
NHI in each area. The NHI’s benefit packages are
comprehensive, including inpatient and outpatient ser-
vices, pharmacy services, Chinese medicine and dental
services. Beneficiaries have complete freedom of choice
of providers and therapies, and they do not need to go
through ‘gatekeepers’ in order to obtain medical services
from specialists. The primary source of funding for the
NHI is the payment of premiums shared by the insured,
the employers and the government. In terms of reim-
bursement, the global budget payment system was
adopted in order to contain the growth of medical
expenditure. Within budget limits, the NHI reimburses
contracted providers mostly on a fee-for-service basis,
using uniform national fee schedules. Entering the sec-
ond decade, reform of Taiwan’sN H Ih a sf o c u s e do n
three aspects: quality improvement; financial balance;
and expansion of social participation. In order to
achieve the first two goals, the implementation of risk
adjustment is crucial [33].
Diagnosis-based risk adjustment is still a very new
concept in Asia and all existing risk adjustment technol-
ogies were developed using claims data from Western
countries. Several studies evaluated their performance in
Taiwan [34,35]. However, they were either methodologi-
cally limited (for example, split-validation was not per-
formed), only reported a single measure at individual
level (R
2), or simply focused on total expenditure. Given
that diagnosis-based risk adjustment has different impli-
cations at individual and group level (such as budget
allocation) and across different types of expenditures, it
is necessary to thoroughly examine risk adjustment
models before they can be directly applied in Taiwan. In
addition, in most cases, previous evaluations of risk
adjustment models have used regional datasets or
focused only on sub-population. Taiwan is one of very
few health care systems in the world which has universal
coverage and a single national computerized database
that includes medical diagnosis information on almost
100% of the population. For this reason the results of
this paper have potential policy and methodology impli-
cations for most other high or middle income nations.
In this paper we aimed to assess the performance of
the ACG system using Taiwan’s NHI claims data and to
evaluate how adding EDCs could affect the performance
of the ACG system.
Methods
Data sources
The source of the data was a longitudinal dataset pre-
pared by Taiwan’s BNHI, which is available for research-
ers interested in observing longitudinal changes of
medical utilization. Individuals’ identifiers in this dataset
have been encrypted in order to protect privacy and
confidentiality, and this study has been approved by the
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Review Board. This dataset contained enrollment and
claims files of a randomly chosen 1% of Taiwan’sp o p u -
lation (about 200,000 individuals). The enrollment files
contained individual subscription information and
demographic factors, including sex, date of birth, type of
beneficiaries and location. The claims files contained
comprehensive records of inpatient care, ambulatory
care, pharmacy store, dental care and Chinese medicine
services, including date of service, ICD-9-CM (Interna-
tional Classification of Diseases) diagnosis codes,
claimed medical expenses and the amount of co-pay-
ment for each encounter. The requirement was 12-
months enrollment in year 2002 for concurrent analyses,
while 24 months enrollment in years 2002 and 2003
were required for prospective analyses. The final sample
size was 173,234 in the concurrent and 164,562 in pro-
spective analyses.
Annual health expenditures were aggregated from all
inpatient, outpatient and pharmacy store claimed
expenses for every enrollee, including claimed reimbur-
sement, medication expenses and co-payments; expenses
for dental care and Chinese medicine were excluded
from this aggregation. The total expenditure could be
further divided into inpatient/outpatient/pharmacy store
expenditure, or medical/drug/pharmacy service expendi-
ture. Given that pharmacy store and pharmacy service
expenditure was very small (each accounted for less
than 2.5% of the total expenditure), results of both cate-
gories were not reported. The 2002 expenditure was
used for concurrent analyses while year 2003 expendi-
ture was used for prospective analyses. The unit of
money in Taiwan is the New Taiwan Dollar (NTD); the
exchange rate is about 32 NTD: 1 US dollar as of
November 2009. Demographic factors included: sex;
type of beneficiaries (insured or dependent); categorical
age (0-17, 18-34, 35-49, 50-64, 65+); insurance category
(based on insured’s type of job); residence (three levels
with different degrees of population density); and local-
ity (six regions: Taipei, Northern, Central, Southern,
Kao-Ping and Eastern). Diagnosis-based risk adjustment
factors, including ACGs, ADGs and EDCs, were derived
from the ACG case-mix system (Version 7.1) using the
individuals’ overall ICD-9-CM codes from both inpatient
and outpatient records in 2002 (diagnosis codes from
dental care and Chinese medicine were excluded).
The ACG risk adjustment system
ACG actuarial cells are mutually exclusive health status
categories defined by morbidity pattern, age and sex.
The ACG system assigns all ICD-9-CM codes to one of
32 diagnostic clusters (ADGs) based on five clinical
dimensions: duration; severity; diagnostic certainty;
aetiology; and specialty care involvement [23,24]. Each
ADG is a grouping of diagnosis codes similar in terms
of severity and likelihood of persistence of the health
condition treated over a relevant period of time, typi-
cally 1 year. ADGs are not mutually exclusive and indi-
viduals can have multiple ADGs (up to 32). Individuals
are then placed into one of 93 discrete ACG categories
according to their assigned ADGs, age and sex. The
result is that individuals within a given ACG experi-
enced a similar pattern of morbidity and resource con-
sumption. The Johns Hopkins EDC methodology assigns
each ICD code to a single disease category or EDC;
t h e r ea r e2 6 4E D C si nt o t a l .I C Dc o d e sw i t h i na nE D C
share similar clinical characteristics and are expected to
induce similar types of diagnostic and therapeutic
responses.
Measuring predictive performance
The following risk adjustment models (from the sim-
plest to the most comprehensive) were used to explain
five types of expenditure (total, inpatient, outpatient,
medical and drug), both concurrently and prospectively:
1. Demographics only,
2. ACGs only,
3. ADGs with demographics,
4. ADGs plus selected EDCs with demographics, and
5. Full EDCs with demographics.
Selected EDCs were derived from the results of step-
wise analyses using all EDCs (Additional file 1) and the
final set of selected EDCs were different in concurrent
(33 EDCs) and prospective analyses (19 EDCs). As
expenditure is a non-negative variable, negative pre-
dicted expenditures from models were set at zero.
The performance of five risk adjustment models was
e v a l u a t e da tt w ol e v e l s :a d j u s t e dR
2 and mean absolute
prediction error (MAPE) [22,36] at individual level, and
predictive ratio (PR) at group level. MAPE was the aver-
age of all absolute differences between the observed and
the predicted. MAPEs of different types of expenditure
were divided by their respective means so that results
on different types of expenditures could be compared.
PR was calculated by dividing mean predicted expendi-
ture by mean actual expenditure within a selected group
of subjects. The model performed better if R
2 was lar-
ger, MAPE was smaller and the PR was closer to one.
Split analysis was performed (a randomly selected 70%
of study subjects were used for model development
while the rest was set aside for model validation), and
measures of model performance were obtained from the
validation set to avoid overfitting.
Among these three indicators, R
2 was easily influenced
by outliers [37]. Therefore, three models with different
levels of truncation were performed in order to reduce
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ture); truncation at two standard deviations above mean
of log expenditure plus one; and truncation at the top
0.5%. Definitions of groups used to calculate PR
included actual total expenditure quintiles, disease bur-
den and age/sex group. Disease burden was classified
into six categories from very low to very high morbidity
and was also based on an output of the ACG system. In
concurrent analyses, group classification could only be
based on the 2002 (current) information; in prospective
analyses, however, group classification could be based
on either the 2002 (prior) or the 2003 (current)
information.
Statistical analysis
All statistical analyses were conducted using SAS™ soft-
ware version 9.1. Several statistical methods had been
proposed for the analysis of expenditure and no single
method was seen to be the best under different condi-
tions examined in these studies [38-40]. Comparisons of
these statistical models for the explanation of expendi-
ture are presented in Additional file 2. In this study,
given the very high R
2, the comparable MAPE, the stan-
dard approach usually adopted in studies involving risk
adjustment [41,42] and a very large sample size [16], the
ordinary least squares (OLS) regression model was used.
Results
Characteristics of the population (Table 1)
The distribution of demographic factors and medical
utilization was similar among all subjects included in
concurrent and prospective analyses. About half of the
study subjects were male and 40% were the insured.
The mean age in 2002 was 35 years and 10% were
elderly. About one-third lived in the areas within the
Taipei Branch, while only 2% were from the Eastern
Branch. About 65% were living in rural county areas.
Only 10% had not made any outpatient visit, while 8%
had at least one inpatient stay. About 90% had non-zero
total expenditure and a similar percentage had non-zero
drug expenditure. The 2003 expenditure of the prospec-
tive sample were about the same as the 2002 expendi-
ture of the concurrent sample. Mean total expenditure
was about 14,500 NTDs, among which medical expendi-
ture (10,000 NTDs) was much higher than pharmacy
expenditure (4000 NTDs). Outpatient expenditure (9500
NTDs) was also much higher than inpatient expenditure
(4800 NTDs).
Proportion of total variance explained by the models
(adjusted R
2) (Tables 2 and 3)
In concurrent analyses, the demographic model
explained 4%, the ACGs and ADGs models explained
about 15%, the ADGs plus selected EDCs model and
full EDCs model explained roughly 40% of variances in
the total expenditure. In prospective analyses, the demo-
graphic model explained 4%, the ACGs and ADGs mod-
els explained about 10%, the ADGs plus selected EDCs
model and full EDCs model explained over 20% of var-
iances. In concurrent analyses, the adjusted R
2 of medi-
cal expenditures was much higher than pharmacy
expenditure across all models. In the prospective ana-
lyses, the adjusted R
2 of medical expenditure was only
higher among the two EDCs-related models while com-
parable in other models. In addition, in concurrent ana-
lyses, the adjusted R
2 of outpatient expenditures was
slightly higher in simpler models while comparable to
that of inpatient expenditure in the two EDC-related
models. In prospective analyses, the adjusted R
2 of out-
patient expenditure was always higher across all models.
Comparing adjusted R
2 of concurrent and prospective
analyses, it was found that the lower adjusted R
2 of total
expenditure in prospective analyses was the result of the
lower prospective adjusted R
2 of medical and inpatient
expenditure (the adjusted R
2 of pharmacy and outpati-
ent expenditure from both concurrent and prospective
analyses was similar).
In both concurrent and prospective analyses, trunca-
tion increased adjusted R
2 across all types of expendi-
ture, especially in pharmacy and outpatient expenditure.
The only exception was that the adjusted R
2 of prospec-
tive medical expenditure in the EDC-related models
remained the same after truncation. After truncation,
the adjusted R
2 was higher in pharmacy expenditure
(compared to medical expenditure) and outpatient
expenditure (relative to inpatient expenditure), and the
differences of adjusted R
2 (pharmacy/medical expendi-
ture and inpatient/outpatient expenditure) were much
larger in prospective analyses. We also found that the
adjusted R
2 of pharmacy expenditure increased the most
after truncation. In addition, it also showed that the
more the number of observations truncated, the higher
the adjusted R
2. After truncation at the top 0.5%, the
adjusted R
2 of total expenditure in two EDCs models,
increased from 40% to 53% in concurrent analyses and
from 22% to 29% in prospective analyses; such an
increase was larger in concurrent analyses.
Adjusted R
2 was different between the elderly and
non-elderly group (Table 4). In concurrent analyses, the
adjusted R
2 in four ACG-related risk adjustment models
was always larger in the elderly population, with the
exception of the adjusted R
2 of outpatient expenditure
from the two EDCs models. The biggest difference was
the adjusted R
2 of inpatient expenditure. It was about
20 percentile larger in the elderly population in the
EDC-related models. The adjusted R
2 of total expendi-
ture in the non-elderly population ranged from 1.4% in
the demographic model to 33% in the EDCs-related
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to 45%. In the prospective analyses, the adjusted R
2 in
the elder population was only larger in pharmacy expen-
diture, while smaller or similar in all other expenditure.
The adjusted R
2 in the non-elderly population ranged
from 1.7% in the demographic model to 22% in the
EDC-related models, while in the elderly population it
was from 0.3% to 16%. Demographic models performed
badly in the elderly population in both prospective and
concurrent analyses.
Mean absolute prediction error (%) (Tables 2 and 3)
In concurrent analyses, MAPE of total expenditure in
the demographic model was 109%; that from the ACG
model was 87%, which was better than the ADGs model
(94%), and the MAPEs from the two EDC-related mod-
els were roughly the same (78%). In the prospective ana-
lyses, the MAPE of total expenditure in the
demographic model was 112%. Those of the ACG and
ADG models were close (103%), while the MAPEs of
the two EDCs-related models were about 96%. Both
concurrent and prospective analyses showed that
MAPEs were the smallest in outpatient expenditures,
then total, pharmacy, and medical expenditures, while
the largest MAPEs were from inpatient expenditures.
MAPEs of outpatient expenditures were about half of
those from inpatient expenditures across all models. In
addition, MAPEs were smalleri nc o n c u r r e n ta n a l y s e s
than in prospective analyses.
Predictive ratio (PR) (Tables 5 and 6)
Expenditure levels by quintiles
All models underpredicted total expenditure in the high-
est quintile group while expenditure was overpredicted
in the four other groups. When groups were defined
based on current information (2002 expenditure for the
concurrent and 2003 expenditure for the prospective
analyses), PR decreased from the lowest to the highest
quintile group. There was an especially large drop mov-
ing from the lowest to the second lowest group. Among
the current classification, PR was smaller in concurrent
than prospective analyses. When groups were defined
using prior classification (in prospective analyses only),
the decreasing trend was not clear and PR was much
smaller. In general, comprehensive models usually per-
formed better than simpler models and the demographic
model performed much worse than the other models.
Morbidity status
Overall, comprehensive models tended to perform better
with the exception of the ACG model. The ACG model
performed far better than all other models in concurrent
analyses. PR of people with the lowest morbidity burden
was only about 0.9 in the ACG model but was more
than 100 in the other models. Similarly, all models
tended to overpredict the total expenditure for people
with the lower morbidity burden, who had lower total
expenditure, while underpredicted expenditure for peo-
ple with higher morbidity burden (hence higher total
expenditure). There was no decreasing trend for PR
other than that in the demographic model or current
classification in prospective analyses. PR based on cur-
rent classification usually deviated further from 1 in pro-
spective than in concurrent analyses. PR based on prior
classification was much better than that on current
Table 1 Characteristics of the Taiwanese population for
concurrent and prospective analyses
Concurrent Prospective
Inclusion criteria 2002 12 month
enrollment
2002 & 2003 24
month enrollment
No. of observations 173,234 164,562
Male 50.16% 49.35%
Insured 40.77% 40.93%
Age in 2002 34.86 34.98
Age group in 2002
0 - 17 23.29% 23.84%
18 - 34 28.22% 26.83%
35 - 49 24.96% 25.51%
50 - 64 13.83% 14.19%
65+ 9.70% 9.62%
Bureau of National Health
Insurance branch
Taipei 32.68% 32.52%
North 14.84% 14.81%
Central 19.78% 19.94%
Southern 14.24% 14.42%
Kao-Pin 16.10% 16.03%
Eastern 2.32% 2.27%
Residence level
Special municipality 21.66% 21.31%
City 14.94% 15.13%
County 63.37% 63.56%
Medical utilization Year 2002 Year 2003
1+Outpatient visit/
expenditure
89.99% 89.71%
1+Inpatient visit/expenditure 8.04% 7.17%
1+ Drug expenditure 89.46% 87.77%
1+ Total expenditure 90.38% 90.05%
Total expenditure (NTD/
year)*
14,279 14,741
Medical expenditure (NTD/
year)*
9,968 10,214
Pharmacy expenditure
(NTD/year)*
3,912 4,108
Inpatient expenditure (NTD/
year)*
4,781 4,788
Outpatient expenditure
(NTD/year)*
9,245 9,577
1 US dollar = 32 New Taiwan dollar (NTD) as of November 2009
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expenditures across groups was much smaller.
Age/sex group
Comprehensive models tended to perform better.
Among younger groups, PR deviated further from 1 in
females. However, among elder groups, on the contrary,
deviation was larger in males. Overall, PR was closer to
1 in male compared to the female groups in both con-
current and prospective analyses. In addition, there was
a tendency for all models to overpredict total expendi-
ture in the elder groups while underpredicting in the
younger groups in both genders, especially in prospec-
tive analyses and simpler models.
Discussion
We found that the adjusted R
2 of total expenditures in
concurrent/prospective analyses was about 4% in the
demographic model, 15%/10% in the ACGs or ADGs
models and 40%/22% in the models containing EDCs.
The adjusted R
2 of medical/outpatient expenditure was
always larger than that of pharmacy/inpatient expendi-
ture. The performance of the ADGs plus selected EDCs
models was comparable to that of the full EDCs model.
When predicting expenditure for groups based on
expenditure quintiles, all models underpredicted the
highest group while overpredicting the other four
groups. For population sub-groups selected on morbid-
ity burden, however, the ACGs model had the best per-
formance overall.
The prerequisite for adopting diagnosis-based risk
adjustment models is that individuals’ diagnosis infor-
mation has to be complete and available. Given the con-
sistently high enrollment rate (99% by the end of 2006
[43]), the high NHI-contracted rate of providers (above
90% [43,44]), a comprehensive benefit package and the
centralization of claims data, diagnosis information
Table 2 Concurrent adjusted R-squared and mean absolute prediction error of alternate risk factors and different
categories of expenditure.
Total expenditure Type of expenditure Source of expenditure
Medical Pharmacy Inpatient Outpatient
R
2: (1) raw expenditure
Demographics-only 0.0421 0.0305 0.0266 0.0132 0.0477
ACGs 0.1486 0.1319 0.0597 0.0894 0.1107
ADGs and demographics 0.1709 0.1435 0.0848 0.0976 0.1342
ADGs, 33 EDCs and demographics 0.3895 0.3938 0.155 0.3053 0.3156
264 EDCs and demographics 0.3972 0.3993 0.1638 0.3191 0.3216
R
2: (2) expenditure truncated at 2 standard deviations above mean of log (expenditure+1)
Truncated criterion 595,431 339,360 86,013 262,810 449,657
% of truncated cases 0.24% 0.33% 0.32% 0.33% 0.15%
Demographics-only 0.0701 0.0545 0.1664 0.0299 0.0855
ACGs 0.2275 0.2265 0.3012 0.1753 0.1935
ADGs and demographics 0.2599 0.2523 0.3843 0.1919 0.2323
ADGs, 33 EDCs and demographics 0.4825 0.4492 0.4738 0.3643 0.4321
264 EDCs and demographics 0.4969 0.4695 0.5238 0.3994 0.4409
R
2: (3) expenditure truncated at top 0.5%
Truncated criterion 333,235 250,144 70,948 193,296 115,412
% of truncated cases 0.47% 0.48% 0.44% 0.51% 0.45%
Demographics-only 0.0963 0.0629 0.1785 0.0323 0.1836
ACGs 0.298 0.2576 0.3162 0.1845 0.402
ADGs and demographics 0.3419 0.2873 0.4032 0.2051 0.4767
ADGs, 33 EDCs and demographics 0.517 0.4618 0.4855 0.3626 0.5539
264 EDCs and demographics 0.5414 0.488 0.5377 0.4021 0.588
Mean absolute prediction error: raw expenditure
Demographics-only 109.19% 118.23% 111.02% 174.62% 94.09%
ACGs 86.72% 94.69% 93.40% 144.80% 74.21%
ADGs and demographics 94.42% 105.85% 95.91% 164.70% 75.33%
ADGs, 33 EDCs and demographics 77.93% 86.17% 87.61% 133.71% 68.89%
264 EDCs and demographics 77.57% 87.51% 83.40% 133.32% 68.34%
Number in study sample (validation only): 51,970
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information and is readily available in Taiwan. Among
the 1.25 million unique diagnoses encountered by
173,234 subjects, only 0.393% were non-grouped and
0.78% were unknown to the ACG system. Given the
very small number in both cases, it provided face valid-
ity in the quality of diagnosis and the ability of the ACG
system to process claims data in Taiwan.
One possible weakness of the study is that the coding
may have improved over the study years so that people
with the same condition had more complete ICD codes
reported if they used medical services during a latter
period. Therefore, we examined the number of ICD
codes reported for each person from 2000 to 2003. If
the number did not differ very much, it would imply
that the improved coding might not be a problem for
this analysis. The numbers of ICD codes assigned to
each patient from year 2000 to 2003 were: 17.86, 18.07,
18.62 and 18.20, respectively. Given this slight variation,
it seemed that the increased coding was not likely to be
a problem for this study.
Several risk adjusters have been evaluated in Taiwan,
including catastrophic disease status [45], prior utiliza-
tion [45-48], diagnosis-based models [45-47,49,50] and
pharmacy-based models [34,51]. It was found that prior
utilization yielded the highest R
2.D i a g n o s i s - b a s e dm o d -
els performed better than pharmacy-based models, while
the catastrophic disease status was somewhat less effi-
cient than the pharmacy-based models. The ACG sys-
tem has been examined in several studies [35,49,50,52].
Given the difference in the truncation levels, statistical
methods and how expenditure was calculated, it was dif-
ficult to make direct comparisons. However, the general
findings that the ACGs/ADGs categorical model did not
perform as well as other claims-based risk adjustment
models that document individual diseases (such as the
Table 3 Prospective adjusted R
2 and mean absolute prediction error of alternate risk factors and different categories
of expenditure.
Total expenditure Type of expenditure Source of expenditure
Medical Pharmacy Inpatient Outpatient
R
2: (1) raw expenditure
Demographics-only 0.0442 0.0308 0.0323 0.0146 0.0435
ACGs 0.0853 0.0643 0.0531 0.0312 0.0833
ADGs and demographics 0.1014 0.0714 0.0752 0.0353 0.1022
ADGs, 19 EDCs and demographics 0.2194 0.2154 0.1310 0.0797 0.3285
264 EDCs and demographics 0.2250 0.2196 0.1481 0.0842 0.3281
R
2: (2) expenditure truncated at 2 standard deviation above mean of log (raw expenditure+1)
Truncated criterion 618,385 344,754 98,239 294,026 462,867
% of truncated cases 0.27% 0.37% 0.32% 0.29% 0.19%
Demographics-only 0.0635 0.0516 0.1489 0.0281 0.0710
ACGs 0.1187 0.1015 0.2202 0.0562 0.1305
ADGs and demographics 0.1427 0.1179 0.2943 0.0661 0.1594
ADGs, 19 EDCs and demographics 0.2746 0.2130 0.3483 0.0902 0.3670
264 EDCs and demographics 0.2830 0.2193 0.3972 0.0989 0.3740
R
2: (3) expenditure truncated at top 0.5%
Truncated criterion 356,940 276,041 74,088 194,860 124,309
% of truncated cases 0.49% 0.48% 0.47% 0.50% 0.48%
Demographics-only 0.0889 0.0579 0.1662 0.0326 0.1664
ACGs 0.1580 0.1126 0.2427 0.0611 0.2819
ADGs and demographics 0.1920 0.1310 0.3227 0.0728 0.3454
ADGs, 19 EDCs and demographics 0.2814 0.2105 0.3814 0.0935 0.4207
264 EDCs and demographics 0.2960 0.2177 0.4283 0.1031 0.4495
Mean absolute prediction error: raw expenditure
Demographics-only 111.76% 120.43% 115.22% 180.28% 97.42%
ACGs 102.21% 112.01% 105.59% 172.66% 87.81%
ADGs and demographics 103.64% 115.56% 104.12% 175.53% 87.85%
ADGs, 19 EDCs and demographics 95.83% 106.84% 97.97% 170.66% 80.84%
264 EDCs and demographics 96.52% 108.51% 97.30% 172.85% 81.81%
Number of study sample (validation only): 49,369.
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Page 7 of 13EDCs) and that the adjusted R
2 of outpatient expendi-
ture was much higher than that of inpatient expendi-
ture, still hold in this study.
The performance of the ACGs/ADGs model in Tai-
wan was comparable to what the models had achieved
among the general population in other countries. This
in part suggested that the ACG system can be directly
applied to Taiwan’sN H Is y s t e m .T h el o w e rR
2 perfor-
mance of both categorical models compared to other
disease-specific diagnosis-based models is probably due
to the limited numbers of variables included in both
models and the difference in the grouping algorithm
(ACGs has 93 mutually exclusive categories and ADGs
consist of only 32 binary variables). However, after add-
ing selected disease indicators to the ADGs model, the
performance was comparable to what could be achieved
by other diagnosis-based models (40% concurrently and
22% prospectively in raw total expenditure). This finding
was consistent with results from previous research that
patients of some common and expensive chronic dis-
eases accounted for a relatively large proportion of
healthcare costs and adding these disease indicators
improved the predictive power of the risk adjustment
models [15,17]. It may be necessary to incorporate
important disease indicators if the ACG system were
used. That is the approach used by the current ACG-
PM model in ACG version 7.0 and after.
Quality improvement and financial balance are two of
three main goals of Taiwan’sN H Ir e f o r ms e tu pb yt h e
NHI’s Second Generation Planning Committee [33] and
both require strong risk adjustment tools. One major
approach suggested by the Committee to achieve quality
improvement is to release valid and understandable
quality information regarding healthcare providers to
the public in order that beneficiaries can make informed
decisions. However, before quality information can be
released, it is important and necessary to implement risk
adjustment so that patient differences across healthcare
organizations are controlled for and variation in the
quality of care can be attributed to providers. In addi-
tion, the Planning Committee also concluded that the
payment system reform should involve healthcare provi-
ders in taking on more financial responsibility for con-
taining costs and it was suggested that the per-case
Table 4 Concurrent and prospective adjusted R-Squared of raw expenditures by two age groups.
Total expenditure Type of expenditure Source of expenditure
Medical Pharmacy Inpatient Outpatient
Concurrent analyses
The non-elderly population (N = 46,895)
Demographics-only 0.014 0.012 0.006 0.004 0.018
ACGs 0.105 0.1 0.032 0.06 0.076
ADGs and demographics 0.133 0.12 0.05 0.079 0.094
ADGs, 33 EDCs and demographics 0.325 0.348 0.105 0.211 0.316
264 EDCs and demographics 0.329 0.355 0.105 0.219 0.324
The elderly population (N = 5,075)
Demographics-only 0.004 0.001 0.013 0.002 0.005
ACGs 0.158 0.133 0.114 0.113 0.105
ADGs and demographics 0.197 0.164 0.165 0.149 0.137
ADGs, 33 EDCs and demographics 0.452 0.433 0.233 0.418 0.279
264 EDCs and demographics 0.445 0.425 0.229 0.421 0.273
Prospective analyses
The non-elderly population (N = 44,628)
Demographics-only 0.017 0.014 0.008 0.005 0.018
ACGs 0.059 0.049 0.025 0.023 0.055
ADGs and demographics 0.072 0.056 0.038 0.026 0.068
ADGs, 19 EDCs and demographics 0.215 0.237 0.112 0.04 0.351
264 EDCs and demographics 0.218 0.242 0.124 0.045 0.35
The elderly population (N = 4,741)
Demographics-only 0.003 0.002 0.009 0.002 0.003
ACGs 0.063 0.042 0.115 0.023 0.074
ADGs and demographics 0.075 0.047 0.164 0.03 0.096
ADGs, 19 EDCs and demographics 0.166 0.155 0.178 0.097 0.263
264 EDCs and demographics 0.155 0.14 0.196 0.094 0.248
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Page 8 of 13payments and partial capitation should replace the cur-
rent fee-for-service payment system [33]. The imple-
mentation of risk adjustmenti sn e c e s s a r yi no r d e rt o
ensure equity if any form of capitation or budgeted pay-
ment system is used in the future. Both of these issues
are likely to be applicable to most other developed
healthcare systems around the globe.
Given the availability and comprehensiveness of claims
data, Taiwan has the necessary information to imple-
ment diagnosis-based risk adjustment. This study
further shows that the ACG case-mix system performs
comparably to diagnosis-based risk adjustment models
applied in other health care systems and far better than
the demographics-only modelc u r r e n t l ye m p l o y e df o r
the NHI. Therefore, incorporating diagnosis-based risk
adjustment into NHI will be a major task facing health-
care policymakers and administrators in Taiwan.
Limitations
The ACG system was developed using American health
insurance claims; given the differences in healthcare sys-
tems and care-seeking behaviours, it may be necessary
to adjust the risk classification system inherent in the
model so that it can reflect the local patterns of disease
burden and health services utilization, such as Chinese
medicine.
The calculation of an individual’s enrollment period
was a concern in this study. As only an individual’sl a t -
est enrollment record was included in the yearly enroll-
ment files starting from 2003, it was only possible to
calculate the exact length of enrollment before 2003 but
not afterwards. It was assumed in this study that all sub-
jects in the 2003 file were enrolled in NHI starting from
January 2003 for the following reasons: (1) the enroll-
ment type of all enrollment records in 2003 was the
same - ‘transferring in’ indicates that an individual had a
new enrollment record because of the change in insur-
ance identity or unit and they were all enrolled prior to
this change; (2) the enrollment rate was consistently
high in Taiwan; (3) the distribution of individuals’ length
of enrollment in 2003 and after, based on this assump-
tion, was similar to that in 2002 or earlier. The effect of
this assumption was that some subjects who were not
12-month enrollees in 2003 would be included in the
study.
In this analysis people who did not have continuous
enrollment over the study period were excluded. This
led to some differences of characteristics between
Table 5 Concurrent predictive ratios of alternate risk factors and different categories of expenditures.
Group Mean
expenditure
Demographics ACGs ADGs and
demographics
ADGs, 33 EDCs and
demographics
264 EDCs and
demographics
Expenditure group by quintiles (current classification: based on 2002)
0 - 20 267.1 44.127 5.384 6.667 6.034 7.587
20 - 40 1634.4 6.316 3.282 2.845 2.362 2.197
40 - 60 3739.1 2.941 2.439 2.359 1.92 1.742
60 - 80 2898.3 1.658 1.963 2.026 1.556 1.445
80 -100 57344 0.433 0.687 0.752 0.81 0.828
Morbidity burden (current classification: based on 2002 morbidity level)
Non-user 7.6 1688.88 0.924 186.889 170.046 254.982
Very low 1750.8 5.511 1.138 0.407 0.645 0.935
Low 4282 2.323 0.931 0.924 0.932 1.011
Moderate 13290.6 1.168 1.044 1.203 1.07 1.051
High 38526.2 0.561 0.948 1.108 0.991 0.954
Very
High
106731.5 0.313 1.028 0.861 0.971 0.955
Demographic group (sex and age group)
M, 0~18 6312.9 1.982 1.01 1.077 0.981 1.043
M, 18~34 7037.6 1.9 0.949 1.097 1.016 0.997
M, 35~49 10971.9 1.344 1.135 1.058 1.006 0.976
M, 50~64 22590.3 0.679 0.928 0.911 0.975 0.973
M, 65+ 50066.9 0.381 0.798 0.887 0.992 1.023
F, 0~18 6989 1.8 0.887 0.932 0.843 0.89
F, 18~34 8221.8 1.676 1.178 1.388 1.167 1.053
F, 35~49 11974.7 1.208 1.224 1.208 0.993 0.955
F, 50~64 22404.3 0.689 1.137 1.141 1.016 1.009
F, 65+ 43574.6 0.384 0.931 0.974 1.031 1.052
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Page 9 of 13subjects in the analysis sample and the target popula-
tion, which may have moderately affected the generaliz-
ability of the results. It was found that there were
statistically significantly differences in demographics and
medical utilization between those who had full 12-
month enrollment and those who did not in 2002
(Table 7) and between those having 24-month enroll-
ment in both 2002 and 2003 and those having 12-
month enrollment only in 2002 (Table 8). Those
excluded from the analyses had a much higher average
healthcare expenditure and inpatient visits (even though
they did not have full-year enrollment), although a
higher proportion of them did not use any medical
service.
The reason for this seemingly conflicting result might
be that the group without full enrollment mainly con-
sisted of two different types of people: those who died
during the year and those who served in the army in
that year (and thus were removed from this dataset for
national security reasons). People tended to consume a
Table 6 Prospective predictive ratios of alternate risk factors and different categories of expenditures.
Group Mean
expenditure
Demographics ACGs ADGs and
demographics
ADGs, 19 EDCs and
demographics
264 EDCs and
demographics
Expenditure group by quintiles (prior classification: based on 2002)
0 - 20 276.2 3.915 1.427 1.359 1.374 1.617
20 - 40 1646.6 2.212 1.5 1.222 1.189 1.177
40 - 60 3737.7 1.573 1.455 1.3 1.181 1.122
60 - 80 8270 1.31 1.582 1.5 1.318 1.246
80 -100 51801.4 0.537 0.727 0.811 0.872 0.888
Expenditure group by quintiles (current classification: based on 2003)
0 - 20 233.2 52.474 29.365 28.362 27.018 28.393
20 - 40 1513.5 6.949 5.456 4.68 4.474 4.507
40 - 60 3571.8 3.187 3.093 2.76 2.492 2.424
60 - 80 8192.6 1.736 1.982 1.889 1.679 1.632
80 -100 59354.1 0.43 0.525 0.587 0.641 0.649
Morbidity burden (prior classification: based on 2002 morbidity level)
Non-user 3013.8 4.432 1.216 1.449 1.411 1.754
Very low 4081.3 2.483 1.046 0.636 0.837 1.032
Low 5746.9 1.775 0.95 0.879 0.968 1.022
Moderate 15844.5 1.019 1.002 1.05 1.003 0.983
High 34475.8 0.64 1.019 1.099 1.061 1.026
Very
high
78192.9 0.429 1.012 0.922 0.984 0.985
Morbidity burden (current classification: based on 2003 morbidity level)
Non-user 8.2 1592.85 726.045 794.094 755.867 811.262
Very low 1651 6.124 4.273 3.597 3.473 3.641
Low 3965.4 2.571 2.143 1.87 1.798 1.826
Moderate 14477.2 1.125 1.165 1.183 1.168 1.152
High 38039.1 0.578 0.76 0.812 0.808 0.802
Very
high
110996 0.301 0.439 0.48 0.529 0.539
Demographic group (sex and age group)
M, 0~18 6932 1.815 1.005 1.075 1.065 1.097
M, 18~34 7654 1.841 1.018 1.082 1.012 1.041
M, 35~49 11403 1.35 1.218 1.069 1.077 1.059
M, 50~64 24776.7 0.642 0.905 0.835 0.863 0.859
M, 65+ 51787.1 0.386 0.672 0.761 0.85 0.901
F, 0~18 4976.6 2.554 1.38 1.478 1.401 1.409
F, 18~34 7948.9 1.799 1.228 1.392 1.252 1.171
F, 35~49 12074.5 1.253 1.348 1.223 1.125 1.074
F, 50~64 24265.9 0.664 1.054 0.998 1.003 0.973
F, 65+ 43298.1 0.401 0.846 0.882 0.95 1.009
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Page 10 of 13lot more medical resources before they died, so the
average expenditure would increase hugely. On the
other hand, those who served in the army were mostly
in their twenties and, hence, less likely to use medical
services and therefore the proportion of people using
any service decreased. Therefore, the results of this
study may not be fully generalizable to those who died
during the year or were or may be in the army.
Table 7 Characteristics of subjects with continuous and
incomplete enrollment among 2002 enrollees (N =
181,790).
2002 1~11
month
enrollment
2002 12 month
enrollment
Number of observations 8,556 173,234
Male 56.42% 50.16%
Insured 30.89% 40.77%
Age in 2002 32.38 34.86
Age group in 2002
0 - 17 15.45% 23.29%
18 - 34 50.41% 28.22%
35 - 49 18.70% 24.96%
50 - 64 7.47% 13.83%
65+ 7.97% 9.70%
Bureau of National Health
Insurance Branch in 2002
Taipei 39.96% 32.68%
North 16.78% 14.84%
Central 16.66% 19.78%
Southern 11.00% 14.24%
Kao-Pin 13.35% 16.10%
Eastern 2.25% 2.32%
Residence level in 2002
Special municipality 26.57% 21.66%
City 14.56% 14.94%
County 58.87% 63.37%
Medical utilization in 2002*
1+ Outpatient visit/expenditure 76.26% 89.99%
1+ Inpatient visit/expenditure 11.76% 8.04%
1+ Drug expenditure 76.34% 89.46%
1+ Total expenditure 77.57% 90.38%
Total expenditure (NTD/year)† 23,351 14,279
Medical expenditure (NTD/year)
†
17,677 9,968
Pharmacy expenditure (NTD/
year) †
5,309 3,912
Inpatient expenditure (NTD/
year) †
17,209 4,781
Outpatient expenditure (NTD/
year) †
6,007 9,245
* For those without 12 full months enrollment, the actual utilization is
underestimated.
†1 US dollar = 32 New Taiwan dollar (NTD) as of November 2009
Table 8 Characteristics of subjects with continuous and
incomplete enrollment in 2003 among 2002 continuous
enrollees.
2002 12 month
enrollment only
2002 and 2003 24
month enrollment only
Number of
observations
8672 164,562
Male 65.59% 49.35%
Insured 37.80% 40.93%
Age in 2002 32.73 34.98
Age group in 2002
0 - 17 12.88% 23.84%
18 - 34 54.60% 26.83%
35 - 49 14.56% 25.51%
50 - 64 6.85% 14.19%
65+ 11.10% 9.62%
Bureau of National Health Insurance
Branch in 2002
Taipei 34.79% 32.59%
North 15.77% 14.80%
Central 17.60% 19.90%
Southern 11.55% 14.39%
Kao-Pin 17.44% 16.04%
Eastern 2.85% 2.29%
Residence level in
2002
Special
municipality
26.09% 21.43%
City 14.03% 14.99%
County 59.88% 63.58%
Medical utilization
in 2002
1+ Outpatient visit/
expenditure
83.38% 90.34%
1+ Inpatient visit/
expenditure
14.00% 7.73%
1+ Drug expenditure 83.15% 89.79%
1+ Total expenditure 83.99% 90.72%
Total expenditure
(NTD/year)*
31,962 13,348
Medical expenditure
(NTD/year)*
23,835 9,238
Pharmacy
expenditure (NTD/
year)*
7,586 3,718
Inpatient
expenditure (NTD/
year)*
20,141 3,972
Outpatient
expenditure (NTD/
year)*
11,640 9,119
*1 US dollar = 32 New Taiwan dollar (NTD) as of November 2009
Chang and Weiner BMC Medicine 2010, 8:7
http://www.biomedcentral.com/1741-7015/8/7
Page 11 of 13Future research directions
Taiwan’s NHI provides beneficiaries’ comprehensive
drug coverage. With drug information readily available,
it will be interesting to evaluate how a pharmacy-based
risk adjustment model, such as the ACG system’sp h a r -
macy-based morbidity groups (Rx-MG) measures, works
in Taiwan and how much improvement can be made by
including pharmacy information in the claims-based risk
adjustment model. Furthermore, most diagnosis infor-
mation used for risk adjustment models is cross-sec-
tional, due in part to the difficulty of obtaining an
individual’s longitudinal diagnosis information. Given
the universal and lifelong coverage under NHI in Tai-
wan, this setting provides a very good opportunity to
examine how bringing in longitudinal claims data will
affect the performance of risk adjustment models.
Conclusions
Given the availability of claims data and the much better
performance of claims-based risk adjustment models
over the demographics-only model, Taiwan’sg o v e r n -
ment should incorporate claims-based models in the
important policy-setting processes, such as resource
allocation, predictive modeling for high-risk case finding
and cost prediction. The performance of the ACG risk
adjustment system in Taiwan is comparable to that
found in other countries; therefore, this suggests that
the ACG system may be directly applied to Taiwan’s
NHI even though it was originally developed using USA
claims data. In addition, it may be necessary to utilize
the disease indicators component (EDCs) of the ACG
system in order to ensure the highest performance of
the ACG system. Given the experience in Taiwan, it is
very likely that other nations will be able to apply the
ACG system or other similar diagnosis-based risk
adjustment tools if insurance claims or other computer-
ized data sources capturing ambulatory and inpatient
medical diagnoses are available.
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